Daewoong’s Nabota expands into Germany, Austria

Nabota is the only botulinum toxin product from South Korea and Asia that has received approval from the US FDA

Jung-Eun Kim 1
2023-03-02 10:28:56 likesmile@hankyung.com
Bio & Pharma

South Korean drugmaker Daewoong Pharmaceutical Co. said on Tuesday it had launched its botulinum toxin product Nabota in Germany and Austria through its overseas partner Evolus Inc., a US performance beauty company.

This is the second European launch for Nabota, which is sold under the brand name Nuceiva outside Asia, after the UK in September last year. Germany is the second-largest market for botulinum toxin products in the European Union, with an annual market size of 100 billion won ($76 million).

Evolus has teamed up with Novia GmbH, a local distributor of cosmetic medical products in Germany and Austria, to market Nabota since mid-February.

Daewoong Vice President Park Sung-soo said the launch would help Nabota gain recognition and market share in the EU market and showcase the product’s capabilities as a Korean-made botulinum toxin product.

Nabota, which was developed and manufactured by Daewoong, is the only botulinum toxin product from Korea and Asia that has received approval from the US Food and Drug Administration.

As of Feb. 2023, Nabota has been approved by regulators in more than 60 countries and exported to more than 80 countries.

Write to Jung-Eun Kim at likesmile@hankyung.com
##Daewoong Pharmaceutical Evolus Nabota Nuceiva Germany Austria #korea daewoong germany #daewoong nabota germany #daewoong nabota austria #daewoong evolus

Daewoong Pharma wins permission from Singapore for Nabota

Daewoong Pharma wins permission from Singapore for Nabota

Daewoong Phamaceutical's Nabota South Korea's drug development company Daewoong Pharmaceutical said on Thursday that it received on Jan. 20 product approval for its botulinum toxin formulation Nabota (overseas brand name: Nuceiva) from Singapore authorities.The item that received approval this

Daewoong Pharma's botulinum toxin Nabota proves long-lasting effect

Daewoong Pharma's botulinum toxin Nabota proves long-lasting effect

Daewoong Pharma's Nabota (US brand name: Jeuveau) Daewoong Pharmaceutical said on Friday that a high-dose administration of botulinum toxin Nabota (US brand name: Jeuveau) to patients with frown wrinkles showed a six-month long-lasting effect as a result of an interim analysis of a phase 2 clin

Daewoong Pharma's botulinum toxin Nabota wins approval from Australia

Daewoong Pharma's botulinum toxin Nabota wins approval from Australia

Daewoong Pharmaceutical said on Wednesday that its botulinum toxin formulation Nabota (overseas brand name: Nuceiva) won approval in Australia on Jan. 13.The item that received approval this time is Nuceiva 100 units whose application to the Australian authorities had been made by Nabota's cos

Daewoong's Nabota approved for sale in Saudi Arabia, Ukraine

Daewoong's Nabota approved for sale in Saudi Arabia, Ukraine

Daewoong Pharmaceutical's botox product Nabota South Korea’s Daewoong Pharmaceutical Co. has obtained approval for the sale of its botulinum toxin product, Nabota, in Saudi Arabia and Ukraine.Saudi Arabia, one of the largest markets for botulinum toxin, more commonly known as botox, in th
(* comment hide *}